| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/17/1996 | US5585249 Polyhydroxybutyrate and polyphosphate membranes with channels |
| 12/17/1996 | US5585115 Agglomerated particles comprising microcrystalline cellulose and silicon oxide; tensile strength |
| 12/17/1996 | US5585114 Active substance incorporated in matrix material of polysaccharide comprising crystalline straight chain alpha-glucan having helix structure |
| 12/17/1996 | US5585112 Method of preparing gas and gaseous precursor-filled microspheres |
| 12/17/1996 | US5585111 Transdermal delivery device |
| 12/17/1996 | US5585110 Chewing gum composition with fluoride and citric acid |
| 12/17/1996 | US5585109 Cosmetic delivery system for salicylic acid and process for preparation of same |
| 12/17/1996 | US5585108 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| 12/17/1996 | US5585106 Nonspecific defense mechanism; administering phagocytosable particles of a particular size to enhance macrophage oxidizing activity; pretreatment for surgery, prosthetics; anticancer agents; aids |
| 12/17/1996 | US5585103 Induction of cytotoxic T-lymphocyte responses |
| 12/17/1996 | US5585093 Cosmetic deodorant compositions containing encapsulated bicarbonate and liquid fragrance ingredients |
| 12/17/1996 | US5585060 Food wrapping, packaging; coating with zein dispersion, drying |
| 12/17/1996 | US5585050 Inner core containing water soluble, amphiphilic active ingredient and nonaqueous hydrophilic solvent and wall of polymer or copolymer |
| 12/14/1996 | CA2178691A1 Oral formulations of s(+)-ibuprofen |
| 12/14/1996 | CA2178686A1 Oral formulations of s(+)-etodolac |
| 12/13/1996 | CA2178789A1 Hemostyptic and tissue adhesive |
| 12/12/1996 | WO1996039524A1 Methods for enhancement of protective immune responses |
| 12/12/1996 | WO1996039423A2 A method for increasing the electrotransport flux of polypeptides |
| 12/12/1996 | WO1996039422A2 Modification of polypeptide drugs to increase electrotransport flux |
| 12/12/1996 | WO1996039257A1 Electrostatically depositing a medicament powder |
| 12/12/1996 | WO1996039224A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 12/12/1996 | WO1996039222A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 12/12/1996 | WO1996039197A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 12/12/1996 | WO1996039159A1 Collagen-based delivery matrix |
| 12/12/1996 | WO1996039156A2 Phosphate-binding polymers for oral administration |
| 12/12/1996 | WO1996039153A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/12/1996 | WO1996039152A1 Use of locally applied dna fragments |
| 12/12/1996 | WO1996039146A1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 12/12/1996 | WO1996039143A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 12/12/1996 | WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 12/12/1996 | WO1996039139A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 12/12/1996 | WO1996039136A1 Transdermal formulation comprising ropinirole |
| 12/12/1996 | WO1996039134A1 Osteogenetic promoting pharmaceutical composition |
| 12/12/1996 | WO1996039131A1 Topical composition for fungal treatment |
| 12/12/1996 | WO1996039128A1 Protein particles for therapeutic and diagnostic use |
| 12/12/1996 | WO1996039127A1 Alkalinizing potassium salt controlled release preparations |
| 12/12/1996 | WO1996039126A2 Ranitidine salts on magnesium trisilicate as an adsorbate |
| 12/12/1996 | WO1996039125A1 Composition and method for administration of bio-affecting catalysts |
| 12/12/1996 | WO1996039123A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating |
| 12/12/1996 | WO1996039121A1 Submicron liposome suspensions obtained from preliposome lyophilizates |
| 12/12/1996 | WO1996039120A2 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 12/12/1996 | WO1996039100A1 Tissue loading system for implantable biological devices |
| 12/12/1996 | WO1996039098A1 A device for delivering a preselected molecule into the system circulation |
| 12/12/1996 | WO1996039095A1 Ocular inserts |
| 12/12/1996 | WO1996033771A3 Composition and method of enhancing electrotransport agent delivery |
| 12/12/1996 | WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 12/12/1996 | WO1996022110A3 Pharmaceutical products containing thermally-inhibited starches |
| 12/12/1996 | WO1996011949A3 Analogs of keratinocyte growth factor |
| 12/12/1996 | DE19622902A1 Zusammensetzung zur Steigerung der Permeation der Haut, welche Glycerinmonolaurat und Laurylacetat umfassen Comprise composition for enhancing the permeation of the skin which glycerol monolaurate and lauryl acetate |
| 12/12/1996 | DE19520659A1 Compsn. to treat virus infections of skin etc |
| 12/12/1996 | DE19520575A1 Spray or gel compsn. contg. hyaluronic acid and heparin |
| 12/12/1996 | CA2223421A1 Methods for enhancement of protective immune responses |
| 12/12/1996 | CA2223281A1 Alkalinizing potassium salt controlled release preparations |
| 12/12/1996 | CA2223251A1 Electrostatically depositing a medicament powder |
| 12/12/1996 | CA2223108A1 Topical composition for fungal treatment |
| 12/12/1996 | CA2222950A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating |
| 12/12/1996 | CA2222915A1 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/12/1996 | CA2221784A1 Osteogenetic promoting pharmaceutical composition |
| 12/12/1996 | CA2221142A1 Tissue loading system for implantable biological devices |
| 12/12/1996 | CA2220895A1 Protein particles for therapeutic and diagnostic use |
| 12/12/1996 | CA2220146A1 Modification of polypeptide drugs to increase electrotransport flux |
| 12/12/1996 | CA2220060A1 A method for increasing the electrotransport flux of polypeptides |
| 12/12/1996 | CA2219528A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 12/11/1996 | EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA |
| 12/11/1996 | EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 12/11/1996 | EP0747069A2 Implantable medical device |
| 12/11/1996 | EP0747050A1 Pharmaceutical compositions containing irbesartan |
| 12/11/1996 | EP0747046A2 Permeable immunoisolation membrane structures for implantation of cells in host tissue |
| 12/11/1996 | EP0747045A2 In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product |
| 12/11/1996 | EP0747041A2 Petroleum jelly containing cosmetic composition |
| 12/11/1996 | EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid |
| 12/11/1996 | EP0746377A1 In-tandem applicator pads for therapeutic agents |
| 12/11/1996 | EP0746342A1 Biodegradable controlled release melt-spun delivery system |
| 12/11/1996 | EP0746338A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 12/11/1996 | EP0746334A1 Pharmaceutical preparation containing plasminogen activators |
| 12/11/1996 | EP0746331A1 Convertible microemulsion formulations |
| 12/11/1996 | EP0746329A1 Anti-inflammatory factor, method of isolation, and use |
| 12/11/1996 | EP0746325A1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 12/11/1996 | EP0746318A1 Injectable emulsions containing antifungal triazole derivatives |
| 12/11/1996 | EP0746317A1 Sublingual or buccal pharmaceutical composition |
| 12/11/1996 | EP0746311A1 Medicinal patches for percutaneous administration |
| 12/11/1996 | EP0746310A1 Controlled release composition |
| 12/11/1996 | EP0746309A1 Subcutaneous implantable multiple agent delivery system |
| 12/11/1996 | EP0746307A1 Cosmetic compositions |
| 12/11/1996 | EP0746301A1 Self-tanning cosmetic compositions and methods of using the same |
| 12/11/1996 | EP0746294A1 Absorption enhancers for topical pharmaceutical formulations |
| 12/11/1996 | EP0746292A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
| 12/11/1996 | EP0746265A1 In situ dissolution of alginate coatings of biological tissue transplants |
| 12/11/1996 | EP0689419B1 Cosmetic or topical use of an aqueous dispersion based on non-volatile organopolysiloxanes and an acrylamide or homopolymeric copolymer type cross-linked methacryloyloxyethyl trimethylammonium chloride polymer |
| 12/11/1996 | EP0612342B1 Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same |
| 12/11/1996 | EP0510086B1 Interdigitation-fusion liposomes and gels |
| 12/11/1996 | EP0493489B1 Film-enrobed unitary-core medicament and the like |
| 12/11/1996 | CN1137756A Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 12/11/1996 | CN1137751A Hydrophobic preparations |
| 12/11/1996 | CN1137564A Stable transglutaminase preparations and processes for producing them |
| 12/11/1996 | CN1137410A Germicidal anti-inflammatory myogenic plaster for external use and preparation method thereof |
| 12/11/1996 | CN1137408A Traditional Chinese medicine tincture for preventing and curing pruritic dermatitis |
| 12/11/1996 | CN1137406A Yunan Baiyao (White Drug-Powder) tablet and preparation method thereof |
| 12/11/1996 | CN1137405A Chinese herbal medicine composition for preparing non-dependence anti-cancer pain-alleviating drug and preparation thereof |
| 12/11/1996 | CN1137404A Drug for curing pulmonary tuberculosis |